‘Eye of the needle’ is a report on healthcare workers’ occupational exposures to bloodborne viruses such as hepatitis B, hepatitis C, and HIV (Public Health England)
Bibliography: Interventions – Harm Reduction
National intelligence network on drug health harms briefing
January 2020 (Public Health England)
Misuse of illicit drugs and medicines: applying All Our Health
Evidence and guidance to help health professionals identify, prevent or reduce drug-related harm (Public Health England)
ACT Pill Testing Trial 2019 (PDF)
Program evaluation (Australian National University)
Needle Syringe Program National Minimum Data Collection Report 2019
The Needle Syringe Program National Minimum Data Collection (NSP NMDC) supports the National Strategies for blood borne and sexually transmissible infections and complements the annual Australian Needle Syringe Program Survey National Data Report (The Kirby Institute, Australia)
Highlights from the EU Drug Markets Report for policy and practice
This short publication presents the main highlights from the EU Drug Markets Report 2019, targeting policy and practice (EMCDDA)
Global State of Harm Reduction: 2019 updates
The 2019 update to Harm Reduction International’s flagship publication, the Global State of Harm Reduction, includes updates to some of the key data in the report, including the opening of new drug consumption rooms, availability of needle and syringe programs, and references to harm reduction in national policy documents, among many other things
Toolkit containing strategies to prevent drug-related deaths in Scotland updated
A resource containing strategies to reduce drug-related deaths in Scotland has been updated and re-launched by Scottish Drugs Forum
Scottish Affairs Committee calls for decriminalisation and safe drug consumption rooms
The Scottish Affairs Committee publishes its report on Problem Drug Use in Scotland
HIV and people who inject drugs (PDF)
Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report (ecdc)
Deaths of homeless people in England and Wales: 2018
Experimental Statistics of the number of deaths of homeless people in England and Wales. Figures are given for deaths registered in the years 2013 to 2018 (ONS)
Monitoring the elimination of viral hepatitis as a public health threat among people who inject drugs in Europe
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together with its expert network on drug-related infectious diseases (DRID), as a follow-up to the first global health sector strategy on viral hepatitis endorsed by the World Health Assembly in 2016 (EMCDDA)
CDC Awards New Funds to Stop Drug Overdoses, Deaths
As the drug overdose crisis evolves and becomes more complex, the Centers for Disease Control and Prevention (CDC) is providing $301 million in new Overdose Data to Action funds to states and jurisdictions
Drug overdoses can be prevented — new resources released
The EU drugs agency (EMCDDA) launches today three new resources looking at drug overdoses in Europe and the interventions in place to prevent them
Hepatitis C interventions (PDF)
Organisations providing harm reduction services in Europe – analysis and examples (European Harm Reduction Network)
Results from the 10 Prisons Project
Statistics on the level of assaults and random mandatory drug testing within the prisons taking part in the 10 Prisons Project (MoJ)
Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2019 report (PDF)
The aim of the Unlinked Anonymous Monitoring (UAM) Survey of People Who Inject Drugs (PWID) is to monitor the prevalence and incidence of HIV, hepatitis B and hepatitis C infection, and associated injecting risk behaviour in people who inject psychoactive drugs, such as heroin, crack cocaine and amphetamines (Public Health England)
Cannabis and Mental Health (PDF)
Priorities for research in Canada (Mentalhealth Commission)
Australian NSP Survey National Data Report 2014 – 2018
The Australian Needle and Syringe Program Survey (ANSPS) provides serial point prevalence estimates of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (antibody and RNA) and sexual and injecting risk behaviour among people who inject drugs (PWID) in Australia
Report calls for radical rethink on support given to released prisoners recovering from addiction
A major new report examining the help given to prisoners recovering from addiction has set out a series of “blueprints” which its authors say could “transform” the way prisoners are supported once they have served their sentence (University of York)
Drug-related infectious diseases in Europe: update from the EMCDDA expert network
This report presents an overview of infectious diseases among people who inject drugs in Europe, both in the community and in prison settings, covering disease surveillance, outbreak investigations, and prevention and control, for the period up to the end of February 2019 (EMCDDA)
ACMD: avoid Friday prison release to prevent drug relapse and deaths
Prison services could reduce drug-related harms by avoiding releasing vulnerable prisoners on a Friday, the ACMD has today advised the Home Secretary
ACMD report: Custody-community transitions
Report from the Advisory Council on the Misuse of Drugs (ACMD) on how to reduce drug-related harms that occur when people move between custody and the community
The Drugs Information and Monitoring System (DIMS)
Factsheet on drug checking in the Netherlands (Trimbos)
National intelligence network on drug health harms briefing: May 2019
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (Public Health England)
Allowing Pharmacists to Directly Dispense Opioid Antidote Can Sharply Cut Opioid Overdose Deaths
Allowing pharmacists to dispense the opioid antidote naloxone without a physician’s prescription can sharply reduce the incidence of fatal opioid-related overdoses, according to a new RAND Corporation study
Psychotropic Substances – Technical Report
On an annual basis the Psychotropics Control Section of the INCB Secretariat publishes a technical report that provides an overview of the world wide licit manufacture, export, import, stocks and consumption of substances controlled under the Convention on Psychotropic Substances of 1971 (INCB)
Withdrawal Management Services in Canada: The National Treatment Indicators Report (PDF)
The report provides an overview of the use of WM services in Canada in 2015–2016, including episodes of care offered within specialized community-based services and in hospitals (CCSA)
Health, rights and drugs (PDF)
Harm reduction, decriminalization and zero discrimination for people who use drugs (UNAIDS)
Promises to improve health outcomes for people who inject drugs remain unfulfilled as 99% do not have adequate access to harm reduction services
New report by UNAIDS highlights the urgent need to implement a human rights and evidence-informed approach to reach people who inject drugs with essential health service
Take-home Naloxone in England
Local Authority Survey (Release)
Widening the availability of naloxone
Explains regulations that widen the availability of naloxone, a drug used as an antidote for heroin (or other opiate) overdoses (Public Health England)
Survivors of Multiple Disadvantage Discuss Service & Support (PDF)
A report by Peer Researchers for the National Commission on Domestic and Sexual Violence and Multiple Disadvantage
Reformulation of OxyContin to Discourage Abuse Linked to Higher Rates of Hepatitis C Infections
Reformulation of the pain medicine OxyContin in 2010 to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers switched from the prescription medication to injectable heroin, according to a new RAND Corporation study (RAND)
Statement from FDA Commissioner Scott Gottlieb, M.D., on unprecedented new efforts to support development of over-the-counter naloxone to help reduce opioid overdose deaths
With the number of overdose deaths involving prescription and illicit opioids more than doubling over the last seven years to nearly 48,000 in 2017, it’s critical that we continue to address this tragedy from all fronts. This includes new ways to increase availability of naloxone, a drug used to treat opioid overdose (FDA)
Prison health inquiry: government response
The government’s response to the Health and Social Care Committee’s inquiry into prison health (Department of Health and Social Care)
m-Health applications for responding to drug use and associated harms
This paper presents results from a scoping study on the availability of smartphone-based applications in the drugs field within a European and global context (EMCDDA)
Canadian Substance Use Costs and Harms in the Provinces and Territories (2007–2014) PDF
In June 2018, the Canadian Substance Use Costs and Harms Scientific Working Group released the results of a significant new study in a comprehensive technical report, Canadian Substance Use Costs and Harms (2007–2014). The report presents estimates of the economic costs and harms of substance use in Canada for the years 2007 to 2014
National intelligence network on drug health harms briefing: December 2018
This briefing is based on a meeting of the national intelligence network (NIN) on the health harms associated with drug use (PHE)
Just Maintaining the Status Quo?
The experience of long-term participants in Methadone Maintenance Treatment – PDF (dun Laoghaire rathdown drug and alcohol Task force)
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 12
- Next Page »
